Skip to main content

An Overview of Current and Emerging Markers of Alcoholism

  • Chapter
Measuring Alcohol Consumption

Abstract

The main purpose of biological markers of alcohol consumption is to provide valuable tools in the diagnosis and treatment of alcoholism. One can categorize different types of biological markers of alcoholism based on their characteristics and clinical applications as trait markers, state markers, and markers of organ damage.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. B. Bush, S. Shaw, P. Cleary, T. L. Delbanco, and M. D. Aronson (1987) Screening for alcohol abuse using the CAGE questionnaire. Am. J. Med. 82, 231–235.

    PubMed  CAS  Google Scholar 

  2. J. Persson and P. H. Magnusson (1988) Comparison between different methods of detecting patients with excessive consumption of alcohol. Acta Med. Scand. 223, 101–109.

    PubMed  CAS  Google Scholar 

  3. P. Luchi, G. Cortis, and A. Bucarelli (1978) Forensic considerations on the comparison of “serum gammaglutamyltranspeptidase” (“gamma-GT”) activity in experimental acute alcoholic intoxication and in alcoholic car drivers who caused road accidents. Forensic Sci. Intl. 11, 33–39.

    CAS  Google Scholar 

  4. H. Gjerde and J. Morland (1987) Concentrations of carbohydrate-deficient transferrin in dialysed plasma from drunken drivers. Alcohol Alcoholism 22, 271–276.

    CAS  Google Scholar 

  5. H. Orrego, L. M. Blendis, J. E. Blake, B. M. Kapur, and Y. Israel (1979) Reliability of assessment of alcohol intake based on personal interviews in a liver clinic. Lancet 2, 1354–1356.

    PubMed  CAS  Google Scholar 

  6. J. E. Peachey and B. M. Kapur (1986) Monitoring drinking behavior with alcohol dipstick during treatment. Alcoholism: Clin. Exp. Res. 10, 663–666.

    CAS  Google Scholar 

  7. R. K. Fuller, K. K. Lee, and E. Gordis (1988) Validity of self-report in alcoholism research: Results of a Veterans Administration Cooperative Study. Alcoholism: Clin. Exp. Res. 12, 201–205.

    CAS  Google Scholar 

  8. M. Rowland and T. N. Tozer (1989) Clinical Pharmacokinetics: Concepts and Applications (Lea and Febiger, Philadelphia, PA), p. 385.

    Google Scholar 

  9. B. J. McNeil, E. Keeler, and S. J. Adelstein (1975) Primer on certain elements of medical decision making. N. England J. Med. 293, 211–215.

    CAS  Google Scholar 

  10. E. L. Gottfried and E. A. Wagar (1983) Laboratory testing: A practical guide. Disease-A-Month 29, 1–41.

    PubMed  CAS  Google Scholar 

  11. H. C. Sox (1986) Probability theory in the use of diagnostic tests. An introduction to critical study of the literature. Annals Intern. Med. 104, 60–66.

    Google Scholar 

  12. C. R. Cloninger (1980) Neurogenetic adaptive mechanisms in alcoholism. Science 236, 410–416.

    Google Scholar 

  13. C. G. Gottfries, L. Oreland, A. Wiberg, and B. Winblad (1975) Lowered monoamine oxidase activity in brains from alcoholic suicides. J. Neurochem. 25, 667–673.

    PubMed  CAS  Google Scholar 

  14. L. Oreland, A. Wiberg, B. Winblad, C. J. Fowler, C. G. Gottfries, and K. Kiianmaa (1983) The activity of monoamine oxidase-A and-B in brains from chronic alcoholics. 7. Neural Trans. 56, 73–83.

    CAS  Google Scholar 

  15. A. L. von Knorring, M. Bohman, L. von Knorring, and L. Oreland (1985) Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psych. Scand. 72, 51–58.

    Google Scholar 

  16. G. N. Pandey, J. Fawcett, R. Gibbons, D. C. Clark, and J. M. Davis (1988) Platelet monoamine oxidase in alcoholism. Biol. Psychol. 24, 15–24.

    CAS  Google Scholar 

  17. J. L. Sullivan, C. N. Stanfield, S. Schanberg, and J. Cavenar (1978) Platelet monoamine oxidase and serum dopamine-β-hydroxylase activity in chronic alcoholics. Arch. Gen. Psychol. 35, 1209–1212.

    CAS  Google Scholar 

  18. B. A. Faraj, J. D. Lenton, M. Kutner, V. M. Camp, T. W. Stammers, S. R. Lee, P. A. Lolies, and D. Chandora (1987) Prevalence of low monoamine oxidase function in alcoholism. Alcoholism: Clin. Exp. Res. 11, 464–467.

    CAS  Google Scholar 

  19. B. Tabakoff, P. L. Hoffman, J. M. Lee, T. Saito, B. Willard, and F. De Leon Jone (1988) Differences in platelet enzyme activity between alcoholics and nonalcoholics. N. England J. Med. 318, 134–139.

    CAS  Google Scholar 

  20. T. Ritchie, H. S. Kim, R. Cole, J. deVellis, and E. P. Noble (1988) Alcoholinduced alterations in phosphoinositide hydrolysis in astrocytes. Alcohol 5, 183–187.

    PubMed  CAS  Google Scholar 

  21. G. Marone, M. Plaut, and L. M. Lichtenstein (1978) Characterization of a specific adenosine receptor on human lymphocytes. J. Immunol 11, 2153–2159.

    Google Scholar 

  22. L. E. Nagy, I. Diamond, and A. Gordon (1988) Cultured lymphocytes from alcoholic subjects have altered cAMP signal transduction. Proc. Natl. Acad. Sci. USA 85, 6973–6976.

    PubMed  CAS  Google Scholar 

  23. I. Diamond, B. Wrubel, W. Estrin, and A. Gordon (1987) Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes from alcoholic patients. Proc. Natl. Acad. Sci. USA 84, 1413–1416.

    PubMed  CAS  Google Scholar 

  24. E. J. Devor, T. Reich, and C. R. Cloninger (1988) Genetics of alcoholism and related end-organ damage. Semin. Liver Disease 8, 1–11.

    CAS  Google Scholar 

  25. K. Blum, E. P. Noble, P. J. Sheridan, A. Montgomery, T. Ritchie, P. Jagadeeswaran, H. Nogami, A. H. Briggs, and J. B. Cohn (1990) Allelic association of human dopamine D receptor gene in alcoholism. JAMA 263, 2055–2060.

    PubMed  CAS  Google Scholar 

  26. A. M. Bolos, M. E>ean, S. Lucas-Derse, M. Ramsburg, G. L. Brown, and D. Goldman (1990) Population and pedigree studies reveal a lack of association between the dopamine D receptor gene and alcoholism. JAMA 264, 3156–3160.

    PubMed  CAS  Google Scholar 

  27. H. Ishii, S. Yasuraoka, Y. Shigeta, S. Takagi, T. Kamiya, F. Okuno, K. Niyamoto, and M. Tsuchiya (1978) Hepatic and intestinal g am maglutamyltranspeptidase activity: Its activation by chronic ethanol administration. Life Sci. 23, 1393–1398.

    PubMed  CAS  Google Scholar 

  28. G. Gadeholt, J. Aarbakke, E. Dybing, M. Sjoblom, and J. Morland (1980) Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and a chow diet. 7. Pharmacol Exp. Ther. 213, 196–203.

    CAS  Google Scholar 

  29. R. Teschke, A. Brand, and G. Strohmeyer (1977) Induction of hepatic microsomal gamma-glutamyltransferase activity following chronic alcohol consumption. Biochem. Biophys. Res. Comm. 75, 718–724.

    PubMed  CAS  Google Scholar 

  30. S. Shaw and C. S. Lieber (1980) Mechanism of increased gamma glutamyl transpeptidase after chronic alcohol consumption: Hepatic microsomal induction rather than dietary imbalance. Substance Alcohol Actions/Misuse 1, 423–428.

    CAS  Google Scholar 

  31. S. Yamada, J. S. Wilson, and C. S. Lieber (1985) The effects of ethanol and diet on hepatic and serum gammaglutamyltranspeptidase activities in rats. J. Nutrition 115, 1285–1290.

    CAS  Google Scholar 

  32. A. J. Kryszewski, G. Neale, J. B. Whitfield and D. W. Moss (1973) Enzyme changes in experimental biliary obstruction. Clin. Chim. Acta 47, 175–182.

    PubMed  CAS  Google Scholar 

  33. A. Wu, G. Slavin, and A. J. Levi (1976) Elevated serum gammaglutamyltransferase (transpeptidase) and histological liver damage in alcoholism. Am. J. Gastroenterol. 65, 318–323.

    PubMed  CAS  Google Scholar 

  34. A. S. Rosman and C. S. Lieber (1991) Biological markers of alcoholism, in Medical and Nutritional Complications of Alcoholism. C. S. Lieber, ed. (Plenum, New York), in press.

    Google Scholar 

  35. M. Salaspuro (1989) Characteristics of laboratory markers in alcohol-related organ damage. Scand. J. Gastroenterol. 24, 769–780.

    PubMed  CAS  Google Scholar 

  36. S. Shaw, T. M. Worner, M. F. Borysow, R. E. Schmitz, and C. S. Lieber (1979) Detection of alcoholism relapse: Comparative diagnostic value of MCV, GGTP, and AANB. Alcoholism: Clin. Exp. Res. 3, 297–301.

    CAS  Google Scholar 

  37. M. Irwin, S. Baird, T. L. Smith, and M. Schuckit (1988) Use of laboratory tests to monitor heavy drinking by alcoholic men discharged from a treatment program. Am. J. Psychol. 145, 595–599.

    CAS  Google Scholar 

  38. U. J. Behrens, T.M. Worner, and C. S. Lieber (1988) Changes in carbohydratedeficient transferrin levels after alcohol withdrawal. Alcoholism: Clin. Exp. Res. 12, 539–544.

    CAS  Google Scholar 

  39. A. Wu, I. Chanarin, G. Slavin, and A. J. Levi (1975) Folate deficiency in the alcoholic-its relationship to clinical and haematological abnormalities, liver disease and folate stores. Br. J. Haematol. 29, 469–478.

    PubMed  CAS  Google Scholar 

  40. M. W. P. Carney and B. Sheffield (1978) Serum folate and B12 and haematological status of in-patient alcoholics. Br. J. Addict. 73, 3–7.

    CAS  Google Scholar 

  41. C. C. Okany, A. N. Bond, and S. N. Wickramasinghe (1983) Effects of ethanol on cell volume and protein synthesis in a human lymphoblastoid cell line (Raji). Acta Haematol. 70, 24–34.

    PubMed  CAS  Google Scholar 

  42. R. J. L. Davidson and P. J. Hamilton (1978) High mean red cell volume: Its incidence and significance in routine haematology. J. Clin. Pathol. 31, 493–498.

    PubMed  CAS  Google Scholar 

  43. H. J. Zimmerman and M. West (1963) Serum enzyme levels in the diagnosis of hepatic disease. Am. J.Gastroenterol. 40, 387–402.

    PubMed  CAS  Google Scholar 

  44. R. J. Clermont and T. C. Chalmers (1967) The transaminase tests in liver disease. Medicine 46, 197–207.

    PubMed  CAS  Google Scholar 

  45. P. Belfrage, B. Berg, I. Hagerstrand, P. Nilsson-Ehle, H. Tornqvist, and T. Wiebe (1977) Alterations of lipid metabolism in healthy volunteers during longterm ethanol intake. Eur. J. Clin. Invest. 7, 127–131.

    PubMed  CAS  Google Scholar 

  46. W. L. Haskell, C. Camargo, P. T. Williams, K. M. Vranizan, R. M. Krauss, F. T. Lindgren, and P. D. Wood (1984) The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study. N. England J. Med. 310, 805–810.

    CAS  Google Scholar 

  47. P. Cushman, J. J. Barboriak, A. Liao, and N. E. Hoffman (1982) Association between plasma high density lipoprotein cholesterol and antipyrine metabolism in alcoholics. Life Sci. 30, 1721–1724.

    PubMed  CAS  Google Scholar 

  48. P. V. Luoma, E. A. Sotaniemi, R. O. Pelkonen, and C. Ehnholm (1982) Highdensity lipoproteins and hepatic microsomal enzyme induction in alcohol consumers. Res. Comm. Chem. Pathol. Pharmacol. 37, 91–96.

    CAS  Google Scholar 

  49. J. Schneider, A. Liesenfeld, R. Mordasini, R. Schubotz, P. Zofel, F. Kubel, C. Vandre-Plozzitzka, and H. Kaffarnik (1985) Lipoprotein fractions, lipoprotein lipase and hepatic triglyceride lipase during short-term and long-term uptake of ethanol in healthy subjects. Atherosclerosis 57, 281–291.

    PubMed  CAS  Google Scholar 

  50. R. Ekman, G. Fex, B. G. Johansson, P. Nilsson-Ehle, and J. Wadstein ( 1981) Changes in plasma high density lipoproteins and lipolytic enzymes after longterm, heavy ethanol consumption. Scand. J. Clin. Lab. Invest. 41, 709–715.

    Google Scholar 

  51. M. R. Taskinen, M. Valimaki, E. A. Nikkila, T. Kuusi, C. Ehnholm, and R. Ylikahri (1982) High density lipoprotein subfractions and postheparin plasma Upases in alcoholic men before and after ethanol withdrawal. Metabolism 31, 1168–1174.

    PubMed  CAS  Google Scholar 

  52. T. Sane, E. A. Nikkila, M. R. Taskinen, M. Valimaki, and R. Ylikahri (1984) Accelerated turnover of very low density lipoprotein triglycerides in chronic alcohol users. A possible mechanism for the up-regulation of high density lipoprotein by ethanol. Atherosclerosis 53, 185–193.

    PubMed  CAS  Google Scholar 

  53. P. Devenyi, G.M. Robinson, B. M. Kapur, and D. A. K. Roncari (1981) High-density lipoprotein cholesterol in male alcoholics with and without severe liver disease. Am. J. Med. 71, 589–594.

    PubMed  CAS  Google Scholar 

  54. G. Heiss, N. J. Johnson, S. Reiland, C. E. Davis, and H. A. Tyroler ( 1980) The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study Summary. Circulation 62 (Suppl. 4), 116–136.

    Google Scholar 

  55. C. J. Glueck (1985) Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: Therapeutic approaches to prevention of atherosclerosis. Am. Heart J. 110, 1107–1115.

    PubMed  CAS  Google Scholar 

  56. C. J. Glueck, P. M. Laskarzewski, D. C. Rao, and J. A. Morrison (1985) Familial aggregation of coronary risk factors, Coronary Artery Disease: Prevention, Complication, and Treatment. W. E. Connor and J. D. Bristow, eds. (J. B. Lippincott, Philadelphia, PA), pp. 173–192.

    Google Scholar 

  57. S. Shaw and C. S. Lieber (1983) Plasma amino acids in the alcoholic: Nutritional aspects. Alcoholism: Clin. Exp. Res. 7, 22–27.

    CAS  Google Scholar 

  58. S. Shaw and C. S. Lieber (1980) Increased hepatic production of alphaamino-n-butyric acid after chronic alcohol consumption in rats and baboons. Gastroenterology 78, 108–113.

    PubMed  CAS  Google Scholar 

  59. S. Shaw and C. S. Lieber (1978) Plasma amino acid abnormalities in the alcoholic. Respective role of alcohol, nutrition, and liver injury. Gastroenterology 74, 677–382.

    PubMed  CAS  Google Scholar 

  60. R. S. Ryback, M. J. Eckardt, B. Felsher, and R. R. Rawlings (1982) Biochemical and hematologic correlates of alcoholism and liver disease. JAMA 248.2261–2265.

    PubMed  Google Scholar 

  61. K. E. Freedland, M. T. Frankel, and R. C. Evenson (1985) Biochemical diagnosis of alcoholism in men psychiatric patients. J. Stud. Alcohol 46, 103–106.

    PubMed  CAS  Google Scholar 

  62. G. Spik, B. Bayard, B. Fournet, G. Strecker, S. Bouquelet, and J. Montreuil (1975) Studies on glycoconjugates: Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett. 50, 296–299.

    PubMed  CAS  Google Scholar 

  63. H. Stibler and S. Borg (1986) Carbohydrate composition of serum transferrin in alcoholic patients. Alcoholism: Clin. Exp. Res. 10, 61–64.

    CAS  Google Scholar 

  64. H. Stibler and S. Borg (1981) Evidence of a reduced sialic acid content in serum transferrin in male alcoholics. Alcoholism: Clin. Exp. Res. 5, 545–549.

    Google Scholar 

  65. S. Petren, O. Vesterberg, and H. Jornvall (1987) Differences among five main forms of serum transferrin. Alcoholism: Clin. Exp. Res. 11, 453–456.

    CAS  Google Scholar 

  66. H. Stibler, O. Sydow, and S. Borg (1980) Quantitative estimation of abnormal microheterogeneity of serum transferrin in alcoholics. Pharmacol. Biochem. Behav. 13 (Suppl.1), 47–51.

    PubMed  Google Scholar 

  67. O. Vesterberg, S. Petren and D. Schmidt (1984) Increased concentrations of a transferrin variant after alcohol abuse. Clin. Chim. Acta 141, 33–39.

    PubMed  CAS  Google Scholar 

  68. E. L. Storey, U. Mack, L. W. Powell, and J. W. Halliday (1985) Use of chromatofocusing to detect a transferrin variant in serum of alcoholic subjects. Clin. Chem. 31, 1543–1545.

    PubMed  CAS  Google Scholar 

  69. F. Schellenberg and J. Weill (1987) Serum desialotransferrin in the detection of alcohol abuse: Definition of a Tf index. Drug Alcohol Depend. 19, 181–191.

    PubMed  CAS  Google Scholar 

  70. H. Stibler and S. Borg (1991) Glycoprotein glycosyltransferase activities in serum in alcohol-abusing patients and healthy controls. Scand. J. Clin. Lab. Invest. 51, 43–51.

    PubMed  CAS  Google Scholar 

  71. H. Stibler, S. Borg, and C. Allgulander (1979) Clinical significance of abnormal heterogeneity of transferrin in relation to alcohol consumption. Acta Med. Scand. 206, 275–281.

    PubMed  CAS  Google Scholar 

  72. A. Kapur, G. Wild, A. Milford-Ward, and D. R. Triger (1989) Carbohydrate deficient transferrin: A marker for alcohol abuse. Br. Med. J. 299, 427–431.

    CAS  Google Scholar 

  73. H. Stibler, S. Borg, and M. Joustra(1986) Micro anion exchange Chromatograph y of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish Patent 8400587-5) Alcoholism: Clin. Exp. Res. 10, 535–544.

    CAS  Google Scholar 

  74. E. L. Storey, G. J. Anderson, U. Mack, L. W. Powell, and J. W. Halliday (1987 ) Desialylated transferrin as a serological marker of chronic excessive alcohol ingestion. Lancet 1, 1292–1294.

    PubMed  CAS  Google Scholar 

  75. U. J. Behrens, T. M. Worner, L. F. Braly, F. Schaffher, and C. S. Lieber (1988) Carbohydrate-deficient transferrin, a marker for chronic alcohol consumption in different ethnic populations. Alcoholism: Clin. Exp. Res. 12, 427–432.

    CAS  Google Scholar 

  76. I. Kwoh-Gain, L. M. Fletcher, J. Price, L. W. Powell, and J. W. Halliday (1990) Desialylated transferrin and mitochondrial aspartate aminotransferase compared as laboratory markers of excessive alcohol consumption. Clin. Chem. 36, 841–845.

    PubMed  CAS  Google Scholar 

  77. Y. Xin, L. M. Lasker and C. S. Lieber (1991) Isoelectric focusing/ Western blotting: A novel and practical method for quantitation of carbohydrate-deficient transferrin in alcoholics. Alcoholism: Clin. Exp. Res. 15, 814–821.

    CAS  Google Scholar 

  78. D. I. Stott (1989) Immunoblotting and dot blotting: J. Immunol. Methods 119.153–187.

    PubMed  Google Scholar 

  79. A. S. Rosman, Y. Xin, K. Galvin, J. M. Lasker, E. Baraona, and C. S. Lieber, ( 1991 ) Comparison of carbohydrate deficient transferrin and red blood cell cysteine as markers of alcohol consumption. Alcoholism: Clin.Exp.Res. 15, 379 (abstract).

    Google Scholar 

  80. R. E. Poupon, F. Schellenberg, B. Nalpas, and J. Weill (1989) Assessment of the transferrin index in screening heavy drinkers from a general practice. Alcoholism: Clin. Exp. Res. 13, 549–553.

    CAS  Google Scholar 

  81. H. Stibler and R. Hultcrantz (1987) Carbohydrate-deficient transferrin in serum in patients with liver diseases. Alcoholism: Clin. Exp. Res. 11, 468–473.

    CAS  Google Scholar 

  82. F. Schellenberg, J. Y. Benard, A. M. Le Goff, C. Bourdin, and J. Weill (1989) Evaluation of carbohydrate-deficient transferrin compared with Tf index and other markers of alcohol abuse. Alcoholism: Clin. Exp. Res. 13, 605–610.

    CAS  Google Scholar 

  83. Y. Xin, J. M. Lasker, A. S. Rosman, and C. S. Lieber. (1991) Carbohydratedeficient transferrin as measured by Western blotting: A practical yet precise marker of alcohol consumption. Gastroenterolgy 100, A812 (abstract).

    Google Scholar 

  84. M. A. Korsten, S. Matsuzaki, L. Feinman, and C. S. Lieber (1975) High blood acetaldehy de levels after ethanol administration. Difference between alcoholic and nonalcoholic subjects. N. England J. Med. 292, 386–389.

    CAS  Google Scholar 

  85. C. Di Padova, T. M. Worner, and C. S. Lieber (1987) Effect of abstinence on the blood acetaldehyde response to a test dose of alcohol in alcoholics. Alcoholism: Clin. Exp. Res. 11, 559–561.

    Google Scholar 

  86. C. M. Peterson and C. M. Polizzi (1987) Improved method for acetaldehyde in plasma and hemoglobin-associated acetaldehyde: Results in teetotalers and alcoholics reporting for treatment. Alcohol 4, 477–480.

    PubMed  CAS  Google Scholar 

  87. E. Baraona, C. Di Padova, J. Tabasco, and C. S. Lieber (1987) Red blood cells: A new major modality for acetaldehyde transport from liver to other tissues. Life Sci. 40, 253–258.

    PubMed  CAS  Google Scholar 

  88. C. M. Peterson, L. Jovanovic-Peterson, and F. Schmid-Formby (1988) Rapid association of acetaldehyde with hemoglobin in human volunteers after low dose ethanol. Alcohol 5, 371–374.

    PubMed  CAS  Google Scholar 

  89. R. Hernandez-Munoz, E. Baraona, I. Blacksberg, and C. S. Lieber (1989) Characterization of the increased binding of acetaldehyde to red blood cells in alcoholics. Alcoholism: Clin. Exp. Res. 13, 654–659.

    CAS  Google Scholar 

  90. R. Uppal, A. S. Rosman, R. Hernandez, E. Baraona and C. S. Lieber (1990) Effect of liver disease on red blood cell acetaldehyde in alcoholics and nonalcoholics. Alcoholism: Clin. Exp. Res. 14, 347 (abstract).

    Google Scholar 

  91. C. Loguercio and G. Nardi (1987) Abnormal concentration of red blood cell cysteine in cirrhotics and its correction by S-adenosylmethionine J. Hepatology 5(Suppl), S161 (abstract).

    Google Scholar 

  92. C. Ailing, L. Gustavsson, and E. Anggard (1983) An abnormal phospholipid in rat organs after ethanol treatment. FEBS Lett. 152, 24–28.

    Google Scholar 

  93. C. Ailing, L. Gustavsson, J. E. Mansson, G. Benthin, and E. Anggard (1984) Phosphatidylethanol formation in rat organs after ethanol treatment. Biochim. Biophy. Acta 793, 119–122.

    Google Scholar 

  94. M. F. Sorrell and D. J. Tuma (1987) The functional implications of acetaldehyde binding to cell constituents. Ann. N.Y. Acad. Sci. 492, 50–62.

    PubMed  CAS  Google Scholar 

  95. M. A. Collins (1988) Acetaldehyde and its condensation products as markers in alcoholism. Recent Devel. Alcohol. 6, 387–403.

    CAS  Google Scholar 

  96. U. J. Behrens, M. Hoerner, J. M. Lasker, and C. S. Lieber (1988) Formation of acetaldehyde adducts with ethanol-inducible P450IIE1 in vivo. Biochem. Biophys. Res. Comm. 154, 584–590.

    PubMed  CAS  Google Scholar 

  97. U. J. Behrens, X. L. Ma, S. Bychenok, E. Baraona, and C. S. Lieber (1990) Acetaldehyde-collagen adduct in CC14-induced liver injury in rats. Biochem. Biophys. Res. Comm. 173, 111–119.

    PubMed  CAS  Google Scholar 

  98. M. A. Collins, W. P. Num, G. F. Borge, G. Teas and C. Goldfarb (1979) Dopamine-related tetrahydroisoquinolines: Significant urinary excretion by alcoholics after alcohol consumption. Science 206, 1184–1186.

    PubMed  CAS  Google Scholar 

  99. B. Sjoquist, S. Borg, and H. Kvande (1981) Catecholamine derived compounds in urine and cerebrospinal fluid from alcoholics during and after long-standing intoxication. Subst. Alcohol Actions /Misuse 2, 63–72.

    CAS  Google Scholar 

  100. B. Sjoquist, S. Borg, and H. Kvande (1981) Salsolinol and methylated salsolinol in urine and cerebrospinal fluid from healthy volunteers. Subst. Alcohol Actions / Misuse 2, 73–77.

    CAS  Google Scholar 

  101. B. A. Faraj, V. M. Camp, D. C. Davis, D. J. Lenton, and M. Kutner (1989) Elevation of plasma salsolinol sulfate in chronic alcoholics as compared to nonalcoholics. Alcoholism: Clin. Exp. Res. 13, 155–163.

    CAS  Google Scholar 

  102. O. Beck, T. R. Bosin, A. Lundman, and S. Borg (1982) Identification and measurement of 6-hydroxy-l-methyl-l,2,3,4-tetrahydro-β-caboline by gas chromatography-mass spectrometry. Biochem. Pharmacol 31, 2517–2521.

    PubMed  CAS  Google Scholar 

  103. H. Rommelspacher, H. Damm, L. Schmidt, and G. Schmidt (1985) Increased excretion of harman by alcoholics depends on events of their life history and the state of the liver. Psychopharmacology 87, 64–68.

    PubMed  CAS  Google Scholar 

  104. J. Adachi, Y. Mizoi, T. Fukunaga, Y. Ueno, H. Imamichi, I. Ninomiya, and T. Naito (1986) Individual difference in urinary excretion of salsolinol in alcoholic patients. Alcohol 3, 371–375.

    PubMed  CAS  Google Scholar 

  105. F. Nomura and C. S. Lieber (1981) Binding of acetaldehyde to rat liver microsomes: Enhancement after chronic alcohol consumption. Biochem. Biophys. Res. Comm. 100, 131–137.

    PubMed  CAS  Google Scholar 

  106. V. J. Stevens, W. J. Fanti, C. B. Newman, R. V. Sims, A. Cerami, and C. M. Peterson (1981) Acetaldehyde adducts with hemoglobin. 7. Clin. Invest. 67, 361–369.

    CAS  Google Scholar 

  107. T. M. Donohue, DJ. Tuma, and M. F. Sorrell (1983) Acetaldehyde adducts with proteins: Binding of [14C] acetaldehyde to serum albumin. Arch. Biochem. Biophys. 220, 239–246.

    PubMed  CAS  Google Scholar 

  108. L. Lumeng and P. J. Durant (1985) Regulation of the formation of stable adducts between acetaldehyde and blood proteins. Alcohol 2, 397–400.

    PubMed  CAS  Google Scholar 

  109. M. J. Savolainen, E. Baraona, and C. S. Lieber (1987) Acetaldehyde binding increases the catabolism of rat serum low-density lipoproteins. Life Sci. 40, 841–846.

    PubMed  CAS  Google Scholar 

  110. Y. A. Kesaniemi, K. Kervinen, and T. A. Miettinen (1987) Acetaldehyde modification of low density lipoprotein accelerates its catabolism in man. Eur. J. Clin. Invest. 17, 29–36.

    PubMed  CAS  Google Scholar 

  111. R. C. Lin, R. S. Smith, and L. Lumeng (1988) Detection of aprotein acetaldehyde adduct in the liver of rats fed alcohol chronically. J. Clin. Invest. 81, 615–619.

    PubMed  CAS  Google Scholar 

  112. R. C. Lin, L. Lumeng, S. Shahidi, T. Kelly, and D. C. Pound (1990) Proteinacetaldehyde adducts in serum of alcoholic patients. Alcoholism: Clin. Exp. Res. 14, 438–443.

    CAS  Google Scholar 

  113. X. Ma, E. Baraona, R. Hernandez-Munoz, and C. S. Lieber (1989) High levels of acetaldehyde in nonalcoholic liver injury after threonine or ethanol administration. Hepatology 10, 933–940.

    PubMed  CAS  Google Scholar 

  114. L. B. Nguyen and C. M. Peterson (1984) The effect of acetaldehyde concentrations on the relative rates of formation of acetaldehyde-modified hemoglobin. Proc. Soc. Exp. Bio. Med. 177, 226–233.

    CAS  Google Scholar 

  115. K. K. Tsuboi, D. J. Thompson, E. M. Rush, and H. C. Schwartz (1981) Acetaldehyde-dependent changes in hemoglobin and oxygen affinity of human erythrocytes. Hemoglobin 5, 241–250.

    PubMed  CAS  Google Scholar 

  116. H. D. Hoberman (1983) Post-translational modification of hemoglobin in alcoholism. Biochem. Biophys. Res. Comm. 113, 1004–1009.

    PubMed  CAS  Google Scholar 

  117. F. R. Homaidan, L. J. Kricka, P. M. S. Clark, S. R. Jones, and T. P. Whitehead (1984) Acetaldehyde-hemoglobin adducts: An unreliable marker of alcohol abuse. Clin. CAem. 30, 480–482.

    CAS  Google Scholar 

  118. H. D. Hoberman and S. M. Chiodo (1982) Elevation of the hemoglobin Al fraction in alcoholism. Alcoholism: Clin. Exp. Res. 6, 260–266.

    CAS  Google Scholar 

  119. T. H. J. Huisman, J. B. Henson, and J. B. Wilson (1983) A new high performance liquid Chromatographic procedure to quantitate hemoglobin A and other minor hemoglobins in blood of normal, diabetic, and alcoholic individuals. J. Lab. Clin. Med. 102, 163–173.

    PubMed  CAS  Google Scholar 

  120. T. L. Stockham and R. V. Blanke (1988) Investigation of an acetaldehydehemoglobin adduct in alcoholics. Alcoholism: Clin. Exp. Res. 12, 748–754.

    CAS  Google Scholar 

  121. R. Mobley and T. H. J. Huisman (1982) Minor hemoglobins (Hb A1) in chronic alcoholic patients. Hemoglobin 6, 79–81.

    PubMed  CAS  Google Scholar 

  122. C. M. Peterson, C. M. Polizzi, and P. J. Frawley (1986) Artefactual increase in hemoglobins A1a+b in blood from alcoholic subjects. Alcoholism: Clin. Exper. Res. 10, 219–220.

    Google Scholar 

  123. E. Gordis and S. Herschkopf (1986) Application of isoelectric focusing in immobilized pH gradients to the study of acetaldehyde-modified hemoglobin. Alcoholism: Clin. Exp. Res. 10, 311–319.

    CAS  Google Scholar 

  124. O. Niemela, Y. Israel, Y. Mizoi, T. Fukunaga, and C. J. P. Eriksson (1990) Hemoglobin-acetaldehyde adducts in human volunteers following acute ethanol ingestion. Alcoholism: Clin. Exp. Res. 14, 838–841.

    CAS  Google Scholar 

  125. Y. Israel, E. Hurwitz, O. Niemela, and R. Arnon (1986) Monoclonal and polyclonal antibodies against acetaldehyde containing epitopes in acetaldehydeprotein adducts. Proc. Natl. Acad. Sci. USA 83, 7923–7927.

    PubMed  CAS  Google Scholar 

  126. M. Hoerner, U. J. Behrens, T. M. Worner, and C. S. Lieber (1986) Humoral immune response to acetaldehyde adducts in alcoholic patients. Res. Comm. Chem. Pathol. Pharmacol. 54, 3–12.

    CAS  Google Scholar 

  127. O. Niemela, F. Klajner, H. Orrego, E. Vidins, L. Blendis, and Y. Israel (1987) Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 7, 1210–1214.

    PubMed  CAS  Google Scholar 

  128. M. Hoerner, U. J. Behrens, T. M. Worner, I. Blacksberg, L. F. Braly, F. Schaffner, and C. S. Lieber (1988) The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 8, 569–574.

    PubMed  CAS  Google Scholar 

  129. Y. Morino, H. Kagamiyama, and H. Wada, (1964) Immunochemical distinction between glutamic-oxaloacetic transaminases from the soluble and mitochondrial fractions of mammalian tissues.J. Biolog. Chem. 239, 943–944.

    CAS  Google Scholar 

  130. H. Ishii, F. Okuno, Y. Shigeta, and M. Tsuchiya (1979) Enhanced serum glutamic oxaloacetic transaminase activity of mitochondrial origin in chronic alcoholics, Currents in Alcoholism., vol. 5, M. Galanter, ed. (Grune and Stratton, New York), pp. 101–108.

    Google Scholar 

  131. B. Nalpas, A. Vassault, S. Charpin, B. Lacour, and P. Berthelot (1986) Serum mitochondrial aspartate aminotransferase as amarker of chronic alcoholism: Diagnostic value and interpretation in a liver unit. Hepatology 6, 608–614.

    Google Scholar 

  132. A. Isaksson, C. Blanche, B. Hultberg, and B. Joelsson (1985) Influence of ethanol on the human serum level of betahexosaminidase. Enzyme 33, 162–166.

    PubMed  CAS  Google Scholar 

  133. B. Hultberg, A. Isaksson, and G. Tiderstrom, (1980) Beta-hexosaminidase, leucine aminopeptidase, cystidyl aminopeptidase, hepatic enzymes and bilirubin in serum of chronic alcoholics with acute ethanol intoxication. Clint Chim. Acta 105.317–323.

    Google Scholar 

  134. P. Karkkainen, K. Poikolainen, and M. Salaspuro (1990) Serum Beta-hexosaminidase as a marker of heavy drinking. Alcoholism: Clin. Exp. Res. 14 187–190.

    CAS  Google Scholar 

  135. B. Hultberg, J. H. Braconier, A. Isaksson, and L. Jansson (1981) Betahexosaminidase level in serum from patients with viral hepatitis as a measure of reticuloendothelial function. Scand. J. Infect. Dis. 13, 241–245.

    PubMed  CAS  Google Scholar 

  136. B. Hultberg, A. Isaksson, and L. Jansson (1981) β-hexosaminidase in serum from patients with cirrhosis and cholestasis. Enzyme 26, 296–300.

    PubMed  CAS  Google Scholar 

  137. B. Hultberg, A. Isaksson, B. Joelsson, A. Alwmark, P. Gullstrand, and S. Bengmark (1983) Pattern of serum beta-hexosaminidase in liver cirrhosis. Scand. J. Gastroenterol. 18, 877–880.

    PubMed  CAS  Google Scholar 

  138. B. Hultberg and A. Isaksson ( 1981 ) A possible explanation for the occurrence of increased Beta-hexosaminidase activity in pregnancy serum. Clin. Chim. Ada 113.135–140.

    Google Scholar 

  139. C. J. Waechter, C.J., and Lennarz, W.J. (1976) The role of polyprenollinked sugars in glycoprotein synthesis. Ann. Rev. Biochem. 45, 95–110.

    PubMed  CAS  Google Scholar 

  140. R. P. Roine, U. Turpeinen, R. Ylikahri, and M. Salaspuro (1987) Urinary dolichol: A new marker of alcoholism. Alcoholism: Clin. Exp. Res. 11, 525–527.

    CAS  Google Scholar 

  141. R. K. Pullarkat and S. Raguthu (1985) Elevated urinary dolichol levels in chronic alcoholics. Alcoholism: Clin. Exp. Res. 9, 28–30.

    CAS  Google Scholar 

  142. R. P. Roine (1988) Effects of moderate drinking and alcohol abstinence on urinary dolichol levels. Alcohol 5, 229–231.

    PubMed  CAS  Google Scholar 

  143. R. Roine, K. Humaloja, J. Hamalainen, I. Nykanen, R. Ylikahri, and M. Salaspuro (1989) Significant increases in urinary dolichol levels in bacterial infections, malignancies and pregnancy but not in other clinical conditions. Ann. of Med. 1, 13–16.

    Google Scholar 

  144. W. J. Powell and G. Klatskin (1968) Duration of survival in patients with Laennec’s cirrhosis. Influence of alcohol withdrawal and possible effects of recent changes in general management of the disease. Am. J. Med. 44, 406–420.

    PubMed  Google Scholar 

  145. C. S. Lieber (1988) Blood markers of alcoholic liver disease. Recent Dev. Alcohol. 6, 351–365.

    PubMed  CAS  Google Scholar 

  146. L. Van Waes and C. S. Lieber (1977) Early perivenular sclerosis in alcoholic fatty liver: An index of progressive liver injury. Gastroenterology 73, 646–650.

    PubMed  Google Scholar 

  147. T. M. Worner and C. S. Lieber (1985) Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254, 627–630.

    PubMed  CAS  Google Scholar 

  148. C. S. Lieber and K. S. Guadagnini (1990) The spectrum of alcoholic liver disease. Hosp. Pract. 25(2A), 51–69.

    CAS  Google Scholar 

  149. S. Lieber,.L. M. DeCarli, K. N. Mak, C. Kim, and M. A. Leo (1990) Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hevatology 12, 1390–1398.

    Google Scholar 

  150. L. Van Waes and C. S. Lieber (1977) Glutamate dehydrogenase: A reliable marker of liver cell necrosis in the alcoholic. Br. Med. J. 2, 1508–1510.

    PubMed  Google Scholar 

  151. S. Sato, T. Nouchi, T. M. Worner, and C. S. Lieber (1986) Liver fibrosis in alcoholics. Detection by Fab radioimmunoassay of serum procollagen III peptides. JAMA 256, 1471–1473.

    PubMed  CAS  Google Scholar 

  152. E. R. Savolainen, B. Goldberg, M. A. Leo, M. Velez, and C. S. Lieber (1984) Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease. Alcoholism: Clin. Exp. Res. 8, 384–389.

    CAS  Google Scholar 

  153. T. Nouchi, T. M. Worner, S. Sato, and C. S. Lieber (1987) Serum procollagen type III N-terminal peptides and laminin PI peptide in alcoholic liver disease. Alcoholism: Clin. Exp. Res. 11, 287–291.

    CAS  Google Scholar 

  154. T. M. Worner and C. S. Lieber (1980) Plasma glutamate dehydrogenase: Clinical application in patients with alcoholic liver disease. Alcoholism: Clin. Exp. Res. 4, 431–434.

    CAS  Google Scholar 

  155. W. G. Guder, A. Habicht, J. Kleissl, U. Schmidt, and O. H. Wieland (1975) The diagnostic significance of liver cell inhomogeneity: Serum enzymes in patients with liver cell necrosis and the distribution of glutamate dehydrogenase in normal human liver. Zeitschrift fur Klinische Chemie und Klinische Biochemie 13, 311–318.

    PubMed  CAS  Google Scholar 

  156. J. Chick, N. Kreitman, and M. Plant (1981) Mean cell volume and gammaglutamyl-transpeptidase as markers of drinking in working men. Lancet 1, 1249–1251.

    PubMed  CAS  Google Scholar 

  157. D. M. Chalmers, M. G. Rinsler, S. MacDermott, C. C. Spicer, and A. J. Levi (1981) Biochemical and haematological indicators of excessive alcohol consumption. Gut 22, 992–996.

    PubMed  CAS  Google Scholar 

  158. G. Bliding, A. Bliding, G. Fex, and C. Tornqvist (1982) The appropriateness of laboratory tests in tracing young heavy drinkers. Drug Alcohol Depend. 10, 153–158.

    PubMed  CAS  Google Scholar 

  159. A. G. Shaper, S. J. Pocock, D. Ashby, M. Walker, and T. P. Whitehead (1985) Biochemical and haematological response to alcohol intake. Ann. Clin. Biochem. 22, 50–61.

    PubMed  CAS  Google Scholar 

  160. A. W. K. Chan, J. W. Weite, and R. B. Whitney (1987) Identification of alcoholism in young adults by blood chemistries. Alcohol 4, 175–179.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rosman, A.S., Lieber, C.S. (1992). An Overview of Current and Emerging Markers of Alcoholism. In: Litten, R.Z., Allen, J.P. (eds) Measuring Alcohol Consumption. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0357-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-0357-5_5

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-6723-2

  • Online ISBN: 978-1-4612-0357-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics